Inflammation in Pregnancy
A special issue of Reproductive Medicine (ISSN 2673-3897).
Deadline for manuscript submissions: closed (31 December 2022) | Viewed by 6983
Special Issue Editor
Interests: placenta development; trophoblast differentiation; cytokines and chemokines in placenta physiology; maternal–fetal cross-talk
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Uncomplicated human pregnancy relies on the finely balanced synergistic crosstalk of inflammatory and immune-modulating factors. Hence, maternal immune functions need to adapt to different stages of pregnancy, which are characterized by unique inflammatory environments. Unrestrained and exaggerated inflammation in human pregnancy is directly associated with the increased mortality and morbidity of the mother and offspring. The major complications of pregnancy, including pre-eclampsia, fetal growth restriction, gestational diabetes and/or obesity (“diabesity”), preterm labor, and miscarriage, are associated with an abnormal maternal inflammatory response, both systemically and locally at the placenta.
Although much progress is being made in understanding the molecular basis of these disorders, a significant knowledge gap still exists in identifying important molecular targets and pathways, which could eventually contribute to the development of new drug therapies and the improvement of pregnancy outcomes.
This Special Issue, “Inflammation in Pregnancy”, will cover a selection of recent research topics and current review articles related to the molecular mechanisms leading to aberrant inflammatory processes in human pregnancy complications. Experimental papers, up-to-date review articles, and commentaries are all welcome.
Dr. Martin Gauster
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reproductive Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pregnancy
- inflammation
- placenta
- pre-eclampsia
- fetal growth restriction
- gestational diabetes
- gestational hypertension
- preterm labor
